00:03 Speaker A

Ah, Labor Day. A nice break as the markets hit pause on Monday. Put away those spreadsheets, folks.

00:43 Speaker A

But don’t get too comfy. Come Friday, all eyes will be on the jobs report for August.

00:49 Speaker A

Economists are whispering about 75,000 new gigs popping up. July’s numbers were a tad lower. However, unemployment might dance at 4.3%, with wages increasing just 0.3% month over month.

00:09 Speaker A

So what’s hot in earnings? Let’s chat Salesforce, Broadcom, and Lululemon.

00:20 Speaker A

Salesforce is dropping its Q2 results on Wednesday. Analysts predict a steady 10% growth, which is just a smidge above Wall Street’s 8.8% forecast. [Learn more about Salesforce](https://finance.yahoo.com/quote/CRM/).

00:30 Speaker A

Even with some sluggish spending, Salesforce isn’t sweating it. Rivals, like Workday, aren’t crying over orders, which means Salesforce might just keep cool too.

00:59 Speaker A

And here’s a political twist for your week. The US Senate Banking Committee is gearing up on Thursday. They’re vetting Stephen Moran for the Fed Reserve Board. It’s gonna be interesting.

01:07 Speaker A

Moran’s stepping in as Adriana Koler’s term wraps up in January. [Read more about the Federal Reserve](https://www.federalreserve.gov/aboutthefed.htm).

Earnings Highlights for the Week

• Salesforce: Expected 10% growth. More on Salesforce.
• Broadcom & Lululemon: Keep a lookout for their reports too.

Important Dates

• Monday: Markets take a breather.
• Wednesday: Salesforce Q2 results.
• Thursday: Senate Banking Committee and Stephen Moran.
• Friday: August jobs report.

With so much happening, grab a coffee and get ready for the whirlwind week ahead!

The post August Employment Update and Federal Nomination Hearing: Key Highlights appeared first on Kingston Global Tokyo Japan.

If you’re keeping an eye on the stock market these days, you’ve probably noticed some drama. The S&P 500 and Nasdaq recently hit new highs, but don’t look too smug if you’ve got money in the Dow. UnitedHealth Group (UNH) has been dragging its feet, pulling things down a bit. Still, with Investor’s Business Daily recommending a solid exposure level of 80% to 100%, the overall vibe is bullish. Lucky for us, the upcoming week promises action with big players like Tesla (TSLA), Alphabet (GOOGL), GE Vernova (GEV), and Lockheed Martin (LMT) all set to report.

electric vehicles: tesla on a bumpy road

Tesla’s prepping to report earnings this Wednesday, and expectations are… meh. Analysts predict a 23% drop in EPS and a 12% slump in revenue. Vehicle sales have taken a hit, too. But Elon Musk always has something up his sleeve. This time, we’re all ears for any updates on the robotaxi service and impacts from past and present administrations’ EV policies. Despite a Q2 slump, folks think U.S. electric vehicle sales will rev up in Q3.

stocks to watch: a buyer’s paradise

It’s been a choppy season for breakouts, yet several stocks are proudly nudging buy signals. Five Below (FIVE), Toast (TOST), LPL Financial (LPLA), Construction Partners (ROAD), and Macom Tech Solutions (MTSI) are in the spotlight. Five Below popped out of a new base after cruising through spring, hovering just above buy levels. Meanwhile, Toast, LPL Financial, and Construction Partners are clearing bases, working through their consolidation tops. Macom might just make a move in the data center chip game.

stock market tech: slowing google’s roll

This week, Google-parent Alphabet checks in after hours on Wednesday. Analysts expect a modest rise in earnings, with EPS estimated at $2.17. Search revenue should grow around 8.7% while cloud computing and YouTube ad revenue are also expected to rise. Everyone’s tuned in for management’s take on margin expansion and AI monetization. Alphabet’s seen better days, sliding down about 2% this year.

energy industry: turbines spinning in circles

GE Vernova’s impressing with a 27% leap since May, but now comes the real test. Expect questions about that elusive gas turbine backlog. It’s critical for many data center projects, and with orders stretching into 2028, the pressure’s on. Earnings are expected to show tremendous growth when it reports this Wednesday.

defense sector: tough guys gearing up

Defense contractors are buckled up for earnings season. Companies like Lockheed Martin, RTX (RTX), and Northrop Grumman (NOC) are ready to report, and General Dynamics (GD) follows soon. L3Harris, Textron (TXT), and Booz Allen Hamilton (BAH) are also on deck. With NATO pledging more defense spending and benefiting from notable bills, these firms are on a roll.

financials: banks making moves

Many foreign banks are outpacing the U.S. markets. Deutsche Bank, Icici Bank, and HDFC Bank are gearing up to give us the scoop. Over in India, Icici and HDBC are set for Saturday earnings. Analysts expect a 5% rise in their earnings, marking a high point for HDBC in seven quarters. Deutsche Bank reports Thursday and is holding strong within a buy range.

health care: watching the hospital horizon

Hospital stocks like Tenet Healthcare get things rolling this Tuesday, with HCA Healthcare on Friday. Updates from managed care firms hint at cost concerns from Medicaid and ACA members. However, changes in Medicaid funding might cloud the future for hospitals.

stock market notebook: blue chip hopes

A light week for Dow earnings, with Verizon (VZ), Coca-Cola (KO), Honeywell (HON), and new kid Sherwin Williams (SHW) reporting soon. Expectations are low, but Coke is doing alright, up 13% this year even if it’s not yet out of the woods.

**SAP** kicks off earnings Tuesday morning, and Boston Scientific follows Wednesday. Meanwhile, **Enova International** is a quiet achiever with strong earnings and sales. Analysts predict slowed, yet impressive growth. Lastly, **Flextronics** is in the hot seat early Thursday, facing potential sales and growth slowdowns.

Need more on stock trends or top picks?

How To Read Stock Charts

The IBD Methodology

Best Growth Stocks To Buy And Watch

The post Upcoming Stock Market Highlights: Tesla, Alphabet, GE Vernova, and Defense Sector appeared first on Kingston Global Tokyo Japan.

There’s something buzzing in the pharmaceutical industry’s pot, and it’s not just the caffeine in our favorite bodega brew. On the crispy morning of December 3, 2024, Bristol Myers Squibb, a heavyweight in the drug-discovering arena, decided to dance with a young, dashing startup, AI Proteins, in what may feel like a cacophony of test tubes and silicon chips. The startup, just three years young, comes with some serious techie credentials. Chris Bahl, PhD, its founder, waxes lyrical about using AI to design cozy, little proteins with just the right drug-like vibe. He says, “AI, synthetic biology, and lab automation are our thang.” Check the full story about the collaboration over at Fierce Biotech.

A Legal Tango

While they’re busy in the lab, the law folks are wrestling with inventorship beef. Back in February 2024, before we even cracked open our Valentine chocolates, the USPTO dropped some wisdom via new guidelines on AI-assisted inventions. This follows hot on the heels of President Biden’s executive order on AI from October 2023, pushing for safe and sound development. The regalo opinions brewing from this masterpiece of bureaucratic brilliance? An idea that an invention is up for grabs by humans only, no AI claim-jumpers allowed. Trust in the firm hand of the USPTO guidance.

Court Cases & Conundrums

Let’s rewind to the 2022 decision in Thaler v. Vidal, a court case many in tech never miss. The Federal Circuit stated, plain as a Staten Island accent: AI systems ain’t inventors. Still, patent stakeholders, particularly those dabbling in biologics, will want to glue their eyes to these matters. Because if AI-designed biologics—a curious love child of tech and chemistry—do start storming the market, future legal battles might just revolve around who really deserves the inventor badge. A glance at AI’s growing role can be sneaked at Nature Medicine and take a look at AbbVie’s approach to AI’s pharma disruption.

Dodging Patent Pitfalls

Biologic innovators are told there’s wisdom in caution. Imagine leaving your patent portfolio soft as a three-day-old bagel. While cooking up new concoctions, firms should ensure that humans are credited with significant contributions. No need to play roulette with your intellectual property, folks. Biosimilar makers, on the other hand, should remain vigilant. Be on the lookout for the legal minefield that may come with AI-designed biologics, particularly in BPCIA or other patent litigation slots. Find a deeper dive on this in Bloomberg Law.

Takeaway Tidbits

• Inventorship Issues: Humans must have a hand on the project, significant enough to be labeled as inventors.
• Future Court Rumbles: Keep those tabs open on recent court decisions that outline AI’s role in invention.
• Biologic Innovation: Biotech firms should ensure that patent portfolios are ironclad against potential AI inventorship challenges.

The big apple and AI seem to be flavor buddies, yet the path ahead holds delightful skirmishes between coding lines and legal lines. Keep watching, and maybe someday soon, your aspirin will come with a little AI-designed friend’s stamp of ingenuity.

The post Ongoing Funding in AI-powered Drug Discovery Highlights Future Importance of Inventorship in Biosimilar Legal Disputes | Notable Law Firm appeared first on Kingston Global Tokyo Japan.

In the city that never sleeps, staying informed about the stock market is like a morning ritual over coffee. Stock Market News, a steadfast companion, feeds us the real-time updates we crave. After all, we’re savvy New Yorkers who are keen on the market’s twists and turns. Whether it’s index tics or toys of big corporations, we stay ahead. Our thumb is forever on the pulse of economic indicators and geopolitical buzz. It’s about stacking up the insights into market dynamics and potential opportunities.

Stock Markets News Today Live: The Dividend Shuffle

• Three companies, including Can Fin Homes, are about to trade ex-dividend. Meanwhile, Wipro’s handing out bonus goodies. Can’t miss that.

In this bustling week ahead, these tickers add a little rhythm to your investment dance. [Read more here](#)

Are Small Caps Making a Comeback?

• After the crash, every expert’s mouth is spewing advice on small caps. A correction sprinkled magic, offering up tasty value picks.

With the storm of geopolitical tensions and policies swirling, volatility might rear its head. But hey, isn’t that where fortunes are made? [Get the details here](#)

Warren Buffet’s Banking Moves: Owning a ‘Castle’

• Take a leaf out of Berkshire Hathaway’s playbook with their banking sector darling. Results don’t lie, folks.

A cash cow among the choice holdings proves why Buffett swears by his ‘castle’ strategy. Wise moves? Absolutely. [Catch the full scoop here](#)

Multibagger Bonanza: A Small-Cap Surge

• There’s chatter about a small-cap NBFC with an eye-popping 5,000% return over five years. They just announced a fundraising via NCDs.

With 3.50% gains on Friday, is there more to suck out from this juice? [Check it out here](#)

Adani’s Ascent and Portfolio Picks

• Adani shares logged their first weekly gain since the fall chill of September. Experts have earmarked Adani Ports, ACC, and Ambuja Cement for some Monday morning shopping.

Can the sunshine last for this major player? Look no further. [Dive deeper here](#)

M&M vs. Hero MotoCorp: The Auto Stock Battle

Motorheads on Wall Street are torn. Do you align with M&M or go the Hero MotoCorp route for long-haul investment bravado? Brokerages weigh in. [Find out who takes the cake here](#)

LIC Defies the Tide

• While peers were slipping, LIC demonstrated resilience with a solid 11% gain over the week. A stock worth watching? Absolutely.

Ever wondered why? We’ve got some illumination on this one. [Get the lowdown here](#)

A Look Back: From Adani Power to Mazagon Dock

• The week was a whirlwind with movers and shakers echoing across boards. Here’s the ultimate wrap-up of this market playbook ending November 29, 2024.

[Take a stroll down memory lane here](#)

Bargain Hunter’s Guide: Expert Picks for Dec 2

• Sumeet Bagadia isn’t holding back. For December 2, his watchlist touts Mahindra & Mahindra, Tata Consumer Products, and ONGC.

If you’re buying, make sure you’re doing it right. [Explore recommendations here](#)

Stock Market Downtime: December Break Schedule

• Missing a market holiday could hamper plans! Here’s a heads-up on the market closures. Some say 17 holidays, some say just one matters.

[Plan accordingly with the details here](#)

In the financial tapestry of our city, news like this is the marrow that informs our decisions. Each insight helps us navigate the urban jungle with confidence, ready for whatever Wall Street throws our way next.

The post Live Updates: Stock Market Highlights for November 30, 2024 – Next Week’s Ex-Dividend and Ex-Bonus Trading Details appeared first on Kingston Global Tokyo Japan.